Download by
Scanning QR Code
No Data
US Stock MarketDetailed Quotes
CHEK Check-Cap
Watchlist
4.0500
+0.2300+6.02% Close 09/21 16:00 ET
4.6250High3.6200Low227.34KVolume
3.7400Open3.8200Pre Close948.27KTurnover3.89%Turnover RatioLossP/E (TTM)23.69MMarket Cap6.539852wk HighLossP/E (Static)5.85MShares1.220052wk Low0.78P/B23.66MFloat Cap1511.9987Historical High--Dividend TTM5.84MShs Float1.2200Historical Low--Div YieldTTM26.31%Amplitude4.1710Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Check-Cap Company
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
News
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mainz Biomed B.V. (MYNZ) and Check-Cap (CHEK)
CervoMed, Tivic Top Healthcare Gainers; Check-Cap, Akari Among Losers
Sector Update: Health Care Stocks Lean Lower Premarket Thursday
Health care stocks were leaning lower premarket Thursday with the iShares Biotechnology ETF (IBB) recently unchanged while the Health Care Select Sector SPDR Fund (XLV) was down 0.6%. Modular Medical
